Core Laboratories Sees Q1 Adj EPS $0.05-$0.07 vs $0.14 Est; Lowers Q1 Sales Guidance from $124.000M-$130.000M to $119.000M-$123.000M vs $128.290M Est

Core Laboratories (NYSE: CLB) has projected its Q1 adjusted earnings per share (EPS) to be between $0.05 and $0.07, significantly lower than the analyst estimate of $0.14. Additionally, the company has revised its Q1 sales guidance down from a range of $124 million to $130 million to a new range of $119 million to $123 million, compared to the previous estimate of $128.29 million.